Showing 1 - 6 results of 6 for search 'Arian Lasocki', query time: 2.15s Refine Results
  1. 1
    How we read: the combined use of MRI and novel PET tracers for the characterisation and treatment planning of masses in neuro-oncology

    How we read: the combined use of MRI and novel PET tracers for the characterisation and treatment planning of masses in neuro-oncology by Arian Lasocki, Rodney J. Hicks

    Published 2019-08-01
    Get full text
    Article
  2. 2
    Improving the diagnosis of radiation necrosis after stereotactic radiosurgery to intracranial metastases with conventional MRI features: a case series

    Improving the diagnosis of radiation necrosis after stereotactic radiosurgery to intracranial metastases with conventional MRI features: a case series by Arian Lasocki, Joseph Sia, Stephen L. Stuckey

    Published 2022-07-01
    Get full text
    Article
  3. 3
    Imaging features associated with H3 K27-altered and H3 G34-mutant gliomas: a narrative systematic review

    Imaging features associated with H3 K27-altered and H3 G34-mutant gliomas: a narrative systematic review by Arian Lasocki, Gehad Abdalla, Geoffrey Chow, Stefanie C. Thust

    Published 2022-11-01
    Get full text
    Article
  4. 4
    Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis

    Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis by Anna Galligan, Anna Galligan, Anna Galligan, Amir Iravani, Amir Iravani, Amir Iravani, Arian Lasocki, Arian Lasocki, Roslyn Wallace, Alison M. Weppler, Nirupa Sachithanandan, Nirupa Sachithanandan, Nirupa Sachithanandan, Cherie Chiang, Cherie Chiang, Cherie Chiang, Peter G. Colman, Peter G. Colman, John Wentworth, John Wentworth, Lavinia Spain, George Au-Yeung, George Au-Yeung, Belinda Lee, Thomas W. H. Kay, Thomas W. H. Kay, Thomas W. H. Kay, Rodney J. Hicks, Shahneen Sandhu, Shahneen Sandhu, Balasubramanian Krishnamurthy, Balasubramanian Krishnamurthy, Balasubramanian Krishnamurthy

    Published 2023-11-01
    Get full text
    Article
  5. 5
    Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES)

    Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES) by Shahneen Sandhu, Grant A McArthur, Kate Drummond, Alison Weppler, Tony Papenfuss, Amir Iravani, Belinda Lee, Richard J Young, Kortnye Smith, Peter Kar Han Lau, Breon Feran, Lorey Smith, Arian Lasocki, Ramyar Molania, Christopher Angel, Hanxian Aw Yeang, Ismael A Vergara, David Kok, Paul Joseph Neeson, Karen E Sheppard, Benjamin J Solomon

    Published 2021-10-01
    Get full text
    Article
  6. 6
    [18F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial

    [18F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial by Eng-Siew Koh, Mustafa Khasraw, Elizabeth H Barnes, Kyle M Walsh, Mark Rosenthal, Rodney J Hicks, Farshad Foroudi, Hui K Gan, Anna K Nowak, Dale L Bailey, Paul Roach, Arian Lasocki, Robyn Leonard, Roel Verhaak, Andrew M Scott, Alisha Moore, Bradford A Moffat, Clare Senko, Roslyn J Francis, Martin Ebert, Sze Ting Lee, Eddie Lau, Greg Fitt, Robert Coffey, Richard De Abreu Lourenco, Lucas Adda, Paul A Thomas, Michael Back

    Published 2023-08-01
    Get full text
    Article

Search Tools: